Abstract
We present here the first impedance-based characterization of the differentiation process of two human mesencephalic fetal neural stem lines. The two dopaminergic neural stem cell lines used in this study, Lund human mesencephalic (LUHMES) and human ventral mesencephalic (hVM1 Bcl-XL), have been developed for the study of Parkinsonian pathogenesis and its treatment using cell replacement therapy. We show that if only relying on impedance magnitude analysis, which is by far the most usual approach in, e.g., cytotoxicity evaluation and drug screening applications, one may not be able to distinguish whether the neural stem cells in a population are proliferating or differentiating. However, the presented results highlight that equivalent circuit analysis can provide detailed information on cellular behavior, e.g. simultaneous changes in cell morphology, cell-cell contacts, and cell adhesion during formation of neural projections, which are the fundamental behavioral differences between proliferating and differentiating neural stem cells. Moreover, our work also demonstrates the sensitivity of impedance-based monitoring with capability to provide information on changes in cellular behavior in relation to proliferation and differentiation. For both of the studied cell lines, in already two days (one day after induction of differentiation) equivalent circuit analysis was able to show distinction between proliferation and differentiation conditions, which is significantly earlier than by microscopic imaging. This study demonstrates the potential of impedance-based monitoring as a technique of choice in the study of stem cell behavior, laying the foundation for screening assays to characterize stem cell lines and testing the efficacy epigenetic control.
Highlights
Parkinson’s disease (PD) is a progressive neurodegenerative disorder mainly affecting the motor functions due to dysfunctional or dying dopamine (DA) producing neurons in substantia nigra pars compacta [1]
In the absence of tetracycline, v-myc expression allows the cells to proliferate into a homogenous population, while addition of tetracycline terminates the expression of v-myc, inducing neuronal differentiation into postmitotic neurons expressing specific markers of dopaminergic neurons and develop long neural projections [24,39]
Using impedance-based monitoring, we present the first characterization of two human mesencephalic fetal neural stem lines (LUHMES and hVM1 Bcl-XL) that have been developed for the study of the pathogenesis of Parkinson’s disease and its treatment by cell replacement therapy (CRT)
Summary
Parkinson’s disease (PD) is a progressive neurodegenerative disorder mainly affecting the motor functions due to dysfunctional or dying dopamine (DA) producing neurons in substantia nigra pars compacta [1]. J Electr Bioimp, 12, 34-49, 2021 replacement therapy (CRT), i.e. transplantation of cells that acquire dopaminergic properties in the brain [1,2]. NSCs from fetal mesencephalon are considered to be one of the potential sources of transplantable cells [1,2]. NSCs must be differentiated into dopaminergic neurons prior to transplantation in order to avoid inefficient transplantation as well as possible tumorigenicity [2]. The purity and yield of cells having dopaminergic phenotype are critical for successful stem cell-based CRT. For these reasons, in vitro characterization of the differentiation process of stem cells is highly important for future development of therapies
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
